GeekWire July 18, 2024
Gillian Dohrn

Bonum Therapeutics is moving into new offices near Seattle’s South Lake Union neighborhood and plans to double its headcount in pursuit of immunotherapy drugs. The biotech startup will occupy the 11th floor of the Alexandria’s new life science tower at 1150 Eastlake Ave. E.

“We’re very excited about 1150,” said CEO John Mulligan. “It’s beautiful, great views. It’ll be a really fun space.”

Mulligan said Bonum discovered the vacancy during the biotech downturn in 2022. The Alexandria building is in an area of Seattle that’s home to multiple biotech startups and life science research organizations, such as Fred Hutchinson Cancer Research and The Allen Institute.

Bonum will move in August from its current offices in the nearby Access...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma / Biotech
Ascentage prices first biotech IPO of 2025, raising $126M
Medicare Reforms Necessitate More Formulary Oversight
Pharma Pulse 1/23/25: Technology’s Role in Trial Design Optimization, Trump's Impact on Medicare Drug Price Negotiations & more
GLP-1 drugs decrease incidence of 42 conditions – but there are risks
Cracking the code of drug delivery: Using computers and AI to make medicine work smarter

Share This Article